HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
A recent high-density linkage screen confirmed that the HLA complex contains the strongest genetic factor for the risk of multiple sclerosis (MS). In parallel, a linkage disequilibrium analysis using 650 single nucleotide polymorphisms (SNP) markers of the HLA complex mapped the entire genetic effect to the HLA-DR-DQ subregion, reflected by the well-established risk haplotype HLA-DRB1*15,DQB1*06. Contrary to this, in a cohort of 1,084 MS patients and 1,347 controls, we show that the HLA-A gene confers an HLA-DRB1 independent influence on the risk of MS (P = 8.4x10(-10)). This supports the opposing view, that genes in the HLA class I region indeed exert an additional influence on the risk of MS, and confirms that the class I allele HLA-A*02 is negatively associated with the risk of MS (OR = 0.63, P = 7x10(-12)) not explained by linkage disequilibrium with class II. The combination of HLA-A and HLA-DRB1 alleles, as represented by HLA-A*02 and HLA-DRB1*15, was found to influence the risk of MS 23-fold. These findings imply complex autoimmune mechanisms involving both the regulatory and the effector arms of the immune system in the triggering of MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Multiple Sclerosis: Association with HL—A3
NAITO, S., NAMEROW, N., MICKEY, M. R., & TERASAKI, P. I. (1972) · Tissue Antigens · doi:10.1111/j.1399-0039.1972.tb00111.x · Cited by 308
A High-Density Screen for Linkage in Multiple Sclerosis
(2005) · The American Journal of Human Genetics · doi:10.1086/444547 · Cited by 297
Cited by
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
“Conditioning on DRB1*15:01, we confirmed the presence of a protective class I allele and identified the signal as being driven by HLA-A*02:01 (as previously suggeste”
BackgroundInteractions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T., Barcellos, L. F., & Alfredsson, L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,185
Autoimmune T cell responses in the central nervous system
Goverman, J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2550 · Cited by 1,030
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies
Urdinguio, R. G., Sanchez-Mut, J. V., & Esteller, M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70262-5 · Cited by 582
The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action
Simmonds, M., & Gough, S. (2007) · Current Genomics · doi:10.2174/138920207783591690 · Cited by 472
“A recent large MS case control study further confirmed an independent protective effect of A*0201 (P = 7 x 10 -12 ), although failed to detect an independent association for A*0301 [59].”
ResultThe immunogenetics of multiple sclerosis: A comprehensive review
Hollenbach, J. A., & Oksenberg, J. R. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.06.010 · Cited by 420
Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci
Patsopoulos, N. A., the Bayer Pharma MS Genetics Working Group, T. S. C. O. S. E. I. A. A. C., & de Bakker, P. I. W. (2011) · Annals of Neurology · doi:10.1002/ana.22609 · Cited by 353
“The network also contains a decrease in HLA-A gene expression relative to the susceptibility allele, which is in agreement with the validation of at least 1 protective allele (HLA-A*02) in this gene.(38) The highest scoring network for the MLANA locus (see Supplementary Fig 4B) contains ERK and connections with type 1…”
ResultEffector T Cells in Multiple Sclerosis
Kaskow, B. J., & Baecher-Allan, C. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029025 · Cited by 314
Patsopoulos, N. A., Barcellos, L. F., Hintzen, R. Q., Schaefer, C., van Duijn, C. M., Noble, J. A., Raj, T., IMSGC, ANZgene, Gourraud, P.-A., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003926 · Cited by 312
“A number of studies have highlighted the importance of class I HLA alleles in MS susceptibility, with HLA-A*02:01 being the most prominent allele [17–20].”
BackgroundThe genetics of multiple sclerosis: an up‐to‐date review
Gourraud, P., Harbo, H. F., Hauser, S. L., & Baranzini, S. E. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01134.x · Cited by 282
Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis
Hedström, A. K., Sundqvist, E., Bäärnhielm, M., Nordin, N., Hillert, J., Kockum, I., Olsson, T., & Alfredsson, L. (2011) · Brain · doi:10.1093/brain/awq371 · Cited by 271
Self-citationLifestyle and Environmental Factors in Multiple Sclerosis
Alfredsson, L., & Olsson, T. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028944 · Cited by 237
“Combined, minus HLA-A 02 and plus DRB1 15:01 equals an OR of ∼5 (Brynedal et al. 2007; Sawcer et al. 2011; Beecham et al. 2013; Moutsianas et al. 2015).”
BackgroundInteraction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis
Hedström, A. K., Lima Bomfim, I., Barcellos, L., Gianfrancesco, M., Schaefer, C., Kockum, I., Olsson, T., & Alfredsson, L. (2014) · Neurology · doi:10.1212/wnl.0000000000000203 · Cited by 225
Multiple Sclerosis and T Lymphocytes: An Entangled Story
Legroux, L., & Arbour, N. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9614-0 · Cited by 196
“, HLA-A*0301) or reduce (HLA-A*0201) the risk of developing MS (Fogdell-Hahn et al. 2000; Harbo et al. 2004; Brynedal et al. 2007; Rubio et al. 2007) suggesting that MHC class I alleles could influence the activation of self-reactive CD8 T lymphocytes (Fugger et al.”
BackgroundPathogenic CD8+ T cells in multiple sclerosis
Friese, M. A., & Fugger, L. (2009) · Annals of Neurology · doi:10.1002/ana.21744 · Cited by 171
“By contrast, an HLA-A2 allele (HLA-A*0201) (which is normally present in trans) apparently protects, roughly halving the relative risks conferred even by HLA-A3 or HLA-DR2 alleles.(28,40) However, the strength of the associations with HLA-DR2 alleles makes it difficult to prove effects of any second alleles.”
BackgroundAn overall view of the most common experimental models for multiple sclerosis
Dedoni, S., Scherma, M., Camoglio, C., Siddi, C., Dazzi, L., Puliga, R., Frau, J., Cocco, E., & Fadda, P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106230 · Cited by 79
From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A
Berge, T., Leikfoss, I., & Harbo, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14034476 · Cited by 45
Metadata
- Authors
- Brynedal, B., Duvefelt, K., Jonasdottir, G., Roos, I. M., Åkesson, E., Palmgren, J., & Hillert, J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-07-25
- Volume
- 2
- Issue
- 7
- Pages
- e664
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1984320937
- Cited by
- 207
- References
- 3
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.